Skip to main content

Polysulfated Glycosaminoglycan (Equine)

Adequan Equine

Calculate dosage
Sourced from primary literature. Awaiting credentialed clinical reviewer — our editorial process.

Drug Class

Supplement

Routes

IM

Indications

Degenerative joint disease

Mechanism of Action

Inhibits catabolic enzymes (metalloproteinases, serine proteases) involved in cartilage degradation. Stimulates synovial fluid production and chondrocyte metabolism.

Side effects & warnings

FDA-approved for equine use. Standard protocol: 500mg IM every 4 days for 7 treatments. Not for use in horses intended for food. Mild transient joint effusion may occur.

Species with Polysulfated Glycosaminoglycan (Equine) dosing data (1 dose rule)

Evidence levels across 1 dose rule

Strong×1

Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.

Backed by a published primary source

  • · FDA NADA Label

Upgrade for Full Details

Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.

View Plans